# Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor

> **NCT02550262** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 40 (actual)

## Conditions studied

- Labor Pain

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Fentanyl
- **DEVICE:** Infusion pump

## Key facts

- **NCT ID:** NCT02550262
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550262, "Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02550262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*